A Double, Blind Placebo-controlled, Randomized Trial to Study Efficacy and Safety of the Viaskin Milk for Treating Milk Induced Eosinophilic Esophagitis in Children

Trial Profile

A Double, Blind Placebo-controlled, Randomized Trial to Study Efficacy and Safety of the Viaskin Milk for Treating Milk Induced Eosinophilic Esophagitis in Children

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Food allergy immunotherapy (Primary)
  • Indications Eosinophilic oesophagitis; Milk hypersensitivity
  • Focus Proof of concept; Therapeutic Use
  • Acronyms SMILEE
  • Most Recent Events

    • 03 Feb 2017 Status changed from recruiting to active, no longer recruiting.
    • 10 Jan 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
    • 10 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top